MIC
VRTX icon

MU Investments Company’s Vertex Pharmaceuticals VRTX Stock Holding History

MU Investments Company’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-220
Closed -$33K – 146
2017
Q4 		$33K Buy
220
+20
+10% +$2.96K 0.02% 71
2017
Q3 		$30K Hold
200
– – 0.02% 120
2017
Q2 		$25K Buy
+200
New +$24.1K 0.02% 164
2015
Q1 		– Sell
-2,600
Closed -$308K – 311
2014
Q4 		$308K Hold
2,600
– – 0.13% 148
2014
Q3 		$296K Sell
2,600
-200
-7% -$19K 0.15% 133
2014
Q2 		$263K Sell
2,800
-300
-10% -$21K 0.12% 182
2014
Q1 		$210K Buy
+3,100
New +$246K 0.1% 209

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

MU Investments Company's VRTX Position: Q1 2018 in Review

MU Investments Company sold out of Vertex Pharmaceuticals (VRTX) in Q1 2018, closing a stake of 220 shares — an estimated $33K sold.

MU Investments Company first reported a position in VRTX in Q1 2014 and held it in 7 quarters. The position peaked at $308K in Q4 2014. 681 funds tracked by Wall St. Rank hold VRTX as of Q1 2018.

  • MU Investments Company reported no remaining Vertex Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • MU Investments Company sold 220 Vertex Pharmaceuticals shares in Q1 2018, an estimated $33K.
  • MU Investments Company first reported a position in Vertex Pharmaceuticals in Q1 2014 and held it in 7 quarters.
  • MU Investments Company's Vertex Pharmaceuticals position peaked at $308K in Q4 2014.
  • 681 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2018.

Based on MU Investments Company's 13F filing for Q1 2018, filed 20 Apr 2018.